Compounds for the treatment of estrogen-dependent illnesses and methods of making and using the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 13, 2002
Issued Date -
N/A
app pub date -
Apr 30, 2001
filing date -
Oct 1, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel sulfatase inhibitor/estrogen receptor blocker compounds useful in the treatment of estrogen dependent illnesses are disclosed. The compounds generally comprise a sulfamate moiety and an aromatic, estrogen receptor blocker moiety. Methods for synthesizing these compounds and using them in the therapeutic and/or prophylactic treatment of an estrogen-dependent disease are also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully